| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K/A | 10-K/A | 10-K/A | 10-K | 10-K/A |
| Revenues: |
| Defense Products | | | 13.4 | 16.6 | 4.7 | 2.3 | 3.0 | 2.6 |
| Commercial Products | | | 9.0 | 10.6 | 5.5 | 5.3 | 4.8 | 6.4 |
| Total revenues | 52.4 | 23.9 | 22.4 | 27.2 | 10.2 | 7.6 | 7.8 | 9.0 |
| Revenue growth [+] | 119.5% | 6.7% | -17.6% | 166.9% | 33.9% | -2.2% | -13.9% | 2.9% |
| Defense Products | | | -19.0% | 253.3% | 104.7% | -22.8% | 14.7% | |
| Commercial Products | | | -15.5% | 93.1% | 3.4% | 10.5% | -25.4% | |
| Cost of goods sold | 23.9 | 16.4 | 19.3 | 21.8 | 6.3 | 4.9 | 5.1 | 5.7 |
| Gross profit | 28.5 | 7.5 | 3.1 | 5.4 | 3.8 | 2.7 | 2.7 | 3.3 |
| Gross margin | 54.5% | 31.5% | 13.7% | 19.8% | 37.8% | 35.6% | 34.9% | 36.4% |
| Selling, general and administrative [+] | 44.5 | 13.7 | 16.9 | 22.9 | 8.7 | 3.2 | 2.8 | 3.0 |
| Sales and marketing | 7.8 | 1.2 | 1.4 | 3.0 | 1.7 | 0.9 | 1.2 | 1.3 |
| General and administrative | 36.7 | 12.5 | 15.5 | 19.8 | 7.0 | 2.3 | 1.6 | 1.8 |
| Research and development | 2.0 | 1.8 | 1.9 | 1.4 | 1.1 | 0.7 | 0.9 | 0.8 |
| Other operating expenses | 0.4 | -2.0 | 3.8 | 0.0 | | | | |
| EBITDA [+] | -15.9 | -5.3 | -16.5 | -16.0 | -5.7 | -1.1 | -0.8 | -0.3 |
| EBITDA growth | 199.4% | -67.8% | 3.1% | 179.3% | 441.5% | 34.1% | 165.7% | 167.6% |
| EBITDA margin | -30.3% | -22.2% | -73.7% | -58.9% | -56.3% | -13.9% | -10.2% | -3.3% |
| Depreciation | 2.1 | 0.4 | 2.6 | 2.4 | 0.2 | 0.2 | 0.2 | 0.1 |
| EBITA | -18.0 | -5.7 | -19.1 | -18.4 | -5.9 | -1.2 | -1.0 | -0.4 |
| EBITA margin | -34.3% | -23.9% | -85.2% | -67.9% | -58.2% | -16.0% | -12.9% | -4.8% |
| Amortization of intangibles | 0.4 | 0.3 | 0.5 | 0.5 | 0.1 | | | 0.1 |
| EBIT [+] | -18.4 | -6.0 | -19.6 | -18.9 | -6.0 | -1.2 | -1.0 | -0.5 |
| EBIT growth | 204.3% | -69.2% | 3.5% | 216.0% | 390.8% | 21.5% | 85.1% | 71.0% |
| EBIT margin | -35.0% | -25.3% | -87.5% | -69.6% | -58.8% | -16.0% | -12.9% | -6.0% |
| Non-recurring items [+] | | | 5.1 | 0.7 | | | | |
| Asset impairment | | | 5.1 | 0.7 | | | | |
| Interest expense, net [+] | 1.9 | 9.6 | 7.3 | 16.2 | 5.0 | -0.1 | | |
| Interest expense | 1.9 | 9.6 | 7.3 | 16.2 | 5.0 | | | |
| Interest income | | | | | | 0.1 | | |
| Other income (expense), net [+] | -3.6 | -17.7 | 1.2 | 2.7 | | | -0.1 | -0.1 |
| Gain (loss) on investments | | | | | | | | -0.2 |
| Other | -1.9 | | | | | | 0.0 | 0.1 |
| Pre-tax income | -23.8 | -33.4 | -30.8 | -33.1 | -11.0 | -1.1 | -1.1 | -0.7 |
| Income taxes | 0.1 | 0.0 | -0.1 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.1% | 0.4% | 0.2% | 0.7% | 1.8% | 0.1% | |
| Minority interest | 0.2 | | 0.0 | -0.7 | -0.3 | | | |
| Earnings from continuing ops | -24.2 | -35.1 | -30.7 | -32.2 | -10.6 | -1.1 | -1.1 | -0.7 |
| Earnings from discontinued ops | | 2.4 | -2.2 | | | | | |
| Net income | -24.2 | -32.7 | -32.9 | -32.2 | -10.6 | -1.1 | -1.1 | -0.7 |
| Net margin | -46.2% | -137.2% | -147.3% | -118.7% | -104.3% | -14.8% | -14.1% | -7.3% |
| |
| Basic EPS [+] | ($0.44) | ($3.65) | ($21.41) | ($444.62) | ($17.02) | ($0.16) | ($0.16) | ($0.10) |
| Growth | -88.1% | -82.9% | -95.2% | 2511.6% | 10394.8% | 0.3% | 67.5% | 5.2% |
| Diluted EPS [+] | ($0.44) | ($3.65) | ($21.41) | ($444.62) | ($17.02) | ($0.16) | ($0.16) | ($0.10) |
| Growth | -88.1% | -82.9% | -95.2% | 2511.6% | 10394.8% | 0.3% | 67.5% | 5.2% |
| |
| Dividends per share [+] | $0.00 | $0.00 | $0.01 | | $0.06 | | | |
| Growth | -82.7% | -83.1% | | -100.0% | | | | |
| |
| Shares outstanding (basic) [+] | 55.4 | 9.6 | 1.4 | 0.1 | 0.6 | 6.9 | 6.8 | 6.8 |
| Growth | 477.2% | 570.1% | 1877.2% | -88.4% | -91.0% | 2.1% | -0.4% | -0.7% |
| Shares outstanding (diluted) [+] | 55.4 | 9.6 | 1.4 | 0.1 | 0.6 | 6.9 | 6.8 | 6.8 |
| Growth | 477.2% | 570.1% | 1877.2% | -88.4% | -91.0% | 2.1% | -0.4% | -0.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |